Below are the top small-cap biotechnology stocks on the NYSE and the NASDAQ in terms of profit margin.
The trailing-twelve-month profit margin at
Enzon Pharmaceuticals IncENZN is 92.30 percent. Enzon Pharmaceuticals' EPS for the same period is $0.65.
The trailing-twelve-month profit margin at
Enanta Pharmaceuticals Inc ENTA is 65.90 percent. Enanta Pharmaceuticals' revenue for the same period is $124.20 million.
The trailing-twelve-month profit margin at
NewLink Genetics Corp NLNK is 59.60 percent. NewLink Genetics' ROE for the same period is 96.50 percent.
The trailing-twelve-month profit margin at
Xenon Pharmaceuticals Inc XENE is 59.20 percent. Xenon Pharmaceuticals' PEG ratio is 1.72.
Loading...
Loading...
ENTAEnanta Pharmaceuticals Inc
$5.792.84%
Edge Rankings
Momentum
7.55
Growth
-
Quality
-
Value
84.07
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in